potential

Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa net sales recorded by Orion has potential to exceed EUR 1 billion in the future

January 14, 2026 01:30 ET  | Source: Orion Oyj ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 14 JANUARY 2026 at…

1 week ago

Boehringer Ingelheim advances potential first-in-class IL-11 inhibitor to Phase II Clinical Research in Idiopathic Pulmonary Fibrosis

Not intended for US and UK audiences BI 765423 has been developed to target IL-11, a key driver of fibrosis…

1 week ago

Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report

Anticipated advancements in weight loss, diabetes, oncology, rare conditions and protein degraders poised to reshape patient careLONDON, Jan. 6, 2026…

2 weeks ago

Cango Receives Buy Rating, Upbeat on its Asset-light Mining Model and AI Potential

DALLAS, Texas, Dec. 24, 2025 /PRNewswire/ -- Greenridge Capital has initiated coverage on Cango Inc. (NYSE: CANG) ("Cango" or the "Company")…

4 weeks ago

FITUR 2026 to be a showcase for India’s great tourism potential and business opportunities with Europe

India strengthens its presence at FITUR at a key moment in the preparation of the India-Spain Dual Year 2026.MADRID, Dec.…

1 month ago

Society Pass Incorporated (Nasdaq: SOPA) Rolls Out M&A Strategy to Capture Potential Significant Valuation Opportunities in Global Landscape of Privately Held Companies

December 15, 2025 10:55 ET  | Source: Society Pass Incorporated NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- As part…

1 month ago

Lynozyfic (linvoseltamab) Monotherapy in Newly Diagnosed Multiple Myeloma (NDMM) Shows Impressive Responses, Supporting Rationale as a Potential Foundation in Frontline Treatment

All three dose groups (50 mg, 100 mg and 200 mg) showed impressive monotherapy efficacy, with VGPR+ (very good partial…

2 months ago

ORIC Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress 2025

December 05, 2025 20:00 ET  | Source: ORIC Pharmaceuticals Highly differentiated 1L preliminary systemic activity of 67% ORR and 100%…

2 months ago

Fenova uPVC Door & Window Systems Recognized by Forbes India DGEMS as a SELECT 200 Company with Global Business Potential

SOLAPUR, India, Dec. 3, 2025 /PRNewswire/ -- Fenova uPVC Door & Window Systems, a division of Arihant Profile – Extrusion…

2 months ago

Crypto Mondays Austin Presents: Regenerative Wealth Where Blockchain, Wellness, Fashion, and Human Potential Meet

Austin, TX, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Crypto Mondays Austin announces Regenerative Wealth, an innovative gathering that merges technology,…

2 months ago